IPO round-up: Lumenis falls short with $75m; Microlin aims for $25m
This article was originally published in Clinica
Executive Summary
Israeli laser specialist Lumenis has priced its initial public offering, but the $75m total is well below the $100m it had been looking for. The Yokneam-based company sold 6.3 million shares at $12 each, short of its $15-17 target. However, the underwriters also have a 30-day option to buy another 937,500 shares, which could top up the total raised.